Blueshift Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Blueshift Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$258K	Sell	7,615 -599	-7%	-$20K	0.06%	420
2026 Q1	$247K	Buy	+8,214	New	+$264K	0.08%	391
2025 Q2	–	Sell	-16,179	Closed	-$249K	–	597
2025 Q1	$249K	Sell	16,179 -2,189	-12%	-$39.1K	0.1%	307
2024 Q4	$405K	Sell	18,368 -22,718	-55%	-$413K	0.15%	196
2024 Q3	$740K	Buy	+41,086	New	+$719K	0.18%	138
2024 Q1	–	Sell	-22,987	Closed	-$240K	–	370
2023 Q4	$240K	Buy	+22,987	New	+$215K	0.13%	212
2023 Q3	–	Sell	-51,585	Closed	-$388K	–	421
2023 Q2	$388K	Buy	51,585 +19,740	+62%	+$160K	0.15%	169
2023 Q1	$282K	Buy	+31,845	New	+$315K	0.12%	233
2022 Q4	–	Sell	-14,699	Closed	-$119K	–	632
2022 Q3	$119K	Sell	14,699 -54,986	-79%	-$486K	0.03%	545
2022 Q2	$524K	Sell	69,685 -21,661	-24%	-$189K	0.09%	318
2022 Q1	$858K	Sell	91,346 -180,906	-66%	-$1.51M	0.08%	305
2021 Q4	$2.18M	Buy	+272,252	New	+$2.46M	0.19%	141
2021 Q3	–	Sell	-66,936	Closed	-$663K	–	1294
2021 Q2	$663K	Buy	+66,936	New	+$708K	0.04%	469

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Blueshift Asset Management's TEVA Position: Q2 2026 in Review

Blueshift Asset Management reduced its Teva Pharmaceuticals (TEVA) stake by 7.3% in Q2 2026, selling an estimated $20K and leaving 7,615 shares worth $258K. The position accounts for 0.06% of the portfolio, ranked #420.

Blueshift Asset Management first reported a position in TEVA in Q2 2021 and has held it in 13 quarters since. The position peaked at $2.18M in Q4 2021. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Blueshift Asset Management held 7,615 shares of Teva Pharmaceuticals worth $258K as of Q2 2026.
Blueshift Asset Management sold 599 Teva Pharmaceuticals shares in Q2 2026, an estimated $20K.
Teva Pharmaceuticals made up 0.06% of Blueshift Asset Management's portfolio in Q2 2026, its #420 holding.
Blueshift Asset Management first reported a position in Teva Pharmaceuticals in Q2 2021 and has held it in 13 quarters since.
Blueshift Asset Management's Teva Pharmaceuticals position peaked at $2.18M in Q4 2021.
673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Blueshift Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.